SEC Form 6-K filed by Hong Kong Pharma Digital Technology Holdings Limited
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________
FORM 6-K
_______________
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2025
Commission File Number 001-42468
_______________
Hong Kong Pharma Digital Technology Holdings Limited
(Registrant’s Name)
_______________
Room B1, 5/F., Well Town Industrial Building,
13 Ko Fai Road, Yau Tong, Kowloon
Hong Kong
(Address of principal executive office)
_______________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Annual General Meeting of Shareholders
On November 24, 2025, Hong Kong Pharma Digital Technology Holdings Limited (the “Company”) announced that it will hold an annual general meeting of shareholders (the “Meeting”) on December 12, 2025 at 10:00 a.m., Hong Kong Time (December 11, 2025, at 9:00 p.m., Eastern Time). The Meeting will be held at Room B1, 5/F., Well Town Industrial Building, 13 Ko Fai Road, Yau Tong, Kowloon, Hong Kong.
In connection with the annual general meeting of shareholders of the Company, the Company hereby furnishes the following documents which are incorporated by reference herein:
Exhibits
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Hong Kong Pharma Digital Technology Holdings Limited |
||||
|
By: |
/s/ Chenyu Liang |
|||
|
Name: |
Chenyu Liang |
|||
|
Title: |
Director and Chief Executive Officer |
|||
Date: November 24, 2025
2